Before Invest
AMGEN INC logo

AMGEN INC

AMGN
Biological Products No Disgnostic Substances
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Unlock 40 quarters
Statement
Period
Annual Quarterly
Order
Format
% Change
Rows
USD ($)
$ in Millions, shares in Millions		Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Jun 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Revenues:
                                                    
Total revenues
$ 10,054
$ 8,618
$ 9,557
$ 9,179
$ 8,149
$ 8,503
$ 8,388
$ 7,447
$ 6,903
$ 6,986
$ 6,105
$ 6,652
Product sales
-
-
-
-
-
-
-
-
-
-
-
-
Other revenues
-
-
-
-
-
-
-
-
-
-
-
-
Operating expenses:
                                                    
Cost of sales
2,811
2,744
3,082
3,011
2,968
3,310
3,236
3,200
1,806
1,813
1,720
1,588
Cost of sales (excludes amortization of certain acquired intangible assets presented separately)
-
-
-
-
-
-
-
-
-
-
-
-
Research and development
1,868
1,719
1,900
1,744
1,486
1,450
1,447
1,343
1,079
1,113
1,058
1,112
Acquired in-process research and development
-
-
-
-
-
-
-
-
-
-
-
0
Selling, general and administrative
1,745
1,602
1,720
1,691
1,687
1,625
1,785
1,808
1,353
1,294
1,258
1,287
Other
116
(113)
329
77
830
71
11
105
644
82
148
5
Amortization of certain acquired intangible assets
-
-
-
-
-
-
-
-
-
-
-
-
Total operating expenses
6,540
5,952
7,031
6,523
6,971
6,456
6,479
6,456
4,882
4,302
4,184
3,992
Operating income
3,514
2,666
2,526
2,656
1,178
2,047
1,909
991
2,021
2,684
1,921
2,660
Other income (expense):
                                                    
Interest expense, net
673
657
685
694
723
776
808
824
759
752
543
368
Other (expense) income, net
(73)
75
2,080
(394)
1,518
1,830
(307)
(235)
685
(318)
2,064
100
Income before income taxes
2,768
2,084
3,921
1,568
1,973
3,101
794
(68)
1,947
1,614
3,442
2,392
Provision for income taxes
393
265
705
136
243
271
48
45
217
235
601
249
Net income
$ 2,375
$ 1,819
$ 3,216
$ 1,432
$ 1,730
$ 2,830
$ 746
$ (113)
$ 1,730
$ 1,379
$ 2,841
$ 2,143
Earnings per share:
                                                    
Basic (in usd per share)
$ 4.4
$ 3.37
$ 5.98
$ 2.66
$ 3.22
$ 5.27
$ 1.39
$ (0.21)
$ 3.23
$ 2.58
$ 5.32
$ 4.01
Diluted (in usd per share)
4.37
3.34
5.93
2.65
3.2
5.22
1.38
(0.21)
3.22
2.57
5.28
3.98
Weighted-average shares used in calculation of earnings per share:
                                                    
Basic (in shares)
540
540
538
538
538
537
537
536
535
535
534
535
Diluted (in shares)
544
544
542
541
541
542
541
536
538
537
538
538
Dividends paid per share (in usd per share)
-
-
-
-
-
-
-
-
-
-
-
-